Drug intelligence / Profile preview

cyanocinnoline

Development stage: Unknown
Lead developer: DuPont
Modality: Small Molecules

Overview

Cyanocinnoline is a synthetic small molecule classified chemically as a cinnoline derivative. Its molecular formula is C24H20N4, with an average molecular weight of 364.45 g/mol. Cyanocinnoline is listed in drug databases as an experimental compound, but there is no evidence of clinical use, approved indications, or detailed pharmacological mechanism available in the public domain. No information on its mechanism of action, therapeutic targets, or disease indications has been published in major medical or regulatory sources[6].

Beyond the preview

Go deeper on cyanocinnoline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyanocinnoline.

Explore the full profile